Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Digi Power X Announces $15 Million Registered Direct Offering of Common Stock
-
iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right
-
TidyCoin Launches to Turn Crypto Clutter Into Deflationary Gold With a First-of-Its-Kind Burn Ecosystem
-
Form 8.3 - [MARLOWE PLC - 18 07 2025] - (CGWL)
-
Form 8.3 - Marlowe plc - Octopus Investments
-
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia
-
Global energy security concerns driving investment in clean energy and tech, and Canadians can benefit: report
-
Osisko Development Secures US$450 Million Financing Facility to Develop the Cariboo Gold Project
-
WAVLINK Unveils the Ultimate Productivity Docking Station: New DisplayLink® Pro DL-7400 Delivers 8K Resolution and Quad-Display Support for Power Users and Enterprise
-
DTC, a Codan Company, Expands Strategic Footprint in Asia-Pacific with Appointment of Colonel Brady Crosier as VP of Business Development
-
National Comprehensive Cancer Network® (NCCN®) Guidelines Recommend Monoclonal Antibodies for COVID-19 Prevention in People with Cancer; New Data Published in JAMA Oncology Underscore Severe Impact
-
Gilat to Report Second Quarter 2025 Results on Wednesday, August 6th
-
HBT Financial, Inc. Announces Second Quarter 2025 Financial Results
-
Kraig Biocraft Laboratories Successfully Completes Lab-to-Field Transition for Three New Spider Silk Production Strains
-
SchoolAI's Deep Canvas Integration Helps Educators Reach Every Student, Every Day
-
SchoolAI's Deep Canvas Integration Helps Educators Reach Every Student, Every Day
-
Rogers Announces Upsizing and Results of its Cash Tender Offers for Canadian Dollar Debt Securities
-
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor A
-
Rogers Announces Results and Upsize of its Cash Tender Offers for Eight Series of U.S. Dollar Debt Securities
-
Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases
-
Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
-
SmartPayNet Expands Payment Services to Over 100 Countries, Strengthening Its Global Presence in High-Risk Payments
-
Beneficient Appoints Tom Hicks as Chairman and James Silk as Interim Chief Executive Officer
-
Tonix Pharmaceuticals Announces the Launch of the “Move Fibro Forward” Campaign to Bring Awareness to Individuals Impacted by Fibromyalgia
-
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
-
DIFI Consortium Calls for Presentations & Announces Date of 2025 Workshop at MILCOM
-
Viva Gold to Present at the Metals & Mining Virtual Investor Conference July 23, 2025
-
BioCryst to Report Second Quarter 2025 Financial Results on August 4
-
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
-
Changes in Nokia Corporation's own shares
-
Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
-
AlorAir Launches the Sentinel WHD Series: The Ultimate Solution for Whole-House Dehumidification
-
Mobilicom Secures $1.4 Million in Orders from a Leading U.S. Drone Manufacturer—Customer Shifting into Mass Production to Meet U.S. Department of Defense Demand
-
SYNO International (SNI) Reaches Strategic Agreement with Indonesian Government, Achieves Breakthrough in the U.S., and Expands Global Presence
-
WEBUY GLOBAL LTD. Launches Groundbreaking AI Travel Assistant Device Powered by DeepSeek V3 Model and Espressif’s ESP32-C
-
NewGen Subsidiary Signs Memorandum of Understanding with Prominent UAE Real Estate Developer
-
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today
-
Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025
-
BioXcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package in Support of Potential Label Expansion for IGALMI®
-
Tastytrade and zerohash Bring Instant Stablecoin Account Funding to Traders Globally
-
Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September
-
BTCS Inc. ETH and Cash Market Value Now $242 Million
-
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
-
Viva Gold to Present at the Metals & Mining Virtual Investor Conference July 23, 2025
-
Dataprana Launches New Energy Division to Expand Its Data Infrastructure Portfolio
-
Changes in Nokia Corporation's own shares
-
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US
-
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
-
Signify share repurchase period update
-
Verizon raises financial guidance for adjusted EBITDA, adjusted EPS and free cash flow after strong Q2 performance
